HIV/AIDS Clinical Trials

The Safety and Effectiveness of Adefovir Dipivoxil Plus Indinavir Combined With Zidovudine or Lamivudine or Stavudine in HIV-Infected Patients Who Have Not Taken Anti-HIV Drugs

Condition: HIV Infections

NCT ID: NCT00002379

A Comparison of Two Anti-HIV Triple-Drug Combinations in HIV-Infected Patients

Condition: HIV Infections

NCT ID: NCT00002168

A Comparison of Epivir Plus Crixivan Combined With Zerit or Retrovir in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs

Condition: HIV Infections

NCT ID: NCT00002369

A Study of Several Anti-HIV Drug Combinations in HIV-Infected Patients Who Have Used Indinavir

Condition: HIV Infections

NCT ID: NCT00000892

A Phase I /II Study of the Protease Inhibitor Indinavir (MK-0639) in Children With HIV Infection

Condition: Acquired Immunodeficiency Syndrome; HIV Infections

NCT ID: NCT00001443

Comparison of New Anti-HIV Drug Combinations in HIV-Infected Children Who Have Taken Anti-HIV Drugs

Condition: HIV Infections

NCT ID: NCT00001083

A Study of Two Anti-HIV Drug Combinations in HIV-Infected Patients

Condition: HIV Infections

NCT ID: NCT00002400

The Effectiveness of Indinavir Plus Zidovudine Plus Lamivudine in HIV-Infected Patients With No Symptoms of Infection

Condition: HIV Infections

NCT ID: NCT00002179

A Study of Three Different Anti-HIV Drug Combinations in HIV-Infected Patients

Condition: HIV Infections

NCT ID: NCT00002410

Effect of Indinavir Plus Two Other Anti-HIV Drugs on Blood Clotting in HIV-Positive Males With Hemophilia

Condition: HIV Infections; Hemophilia A

NCT ID: NCT00002386

A Study to Evaluate the Safety and Tolerance of Combination Anti-HIV Drug Therapy (Indinavir, Lamivudine, and Zidovudine) in HIV-Positive Pregnant Women and Their Infants

Condition: HIV Infections; Pregnancy

NCT ID: NCT00000944

Safety and Effectiveness of Giving Indinavir, Ritonavir, Stavudine, and Lamivudine to HIV-Infected Patients Who Have Never Received Anti-HIV Drugs

Condition: HIV Infections

NCT ID: NCT00002451

A Study to Compare Two Anti-HIV Drug Combinations That Include Amprenavir in HIV-Infected Patients Who Have Failed Anti-HIV Drug Combinations That Did Not Include Amprenavir

Condition: HIV Infections

NCT ID: NCT00002423

A Study of Delavirdine Used Together With Other Anti-HIV Drugs in HIV-Infected Patients

Condition: HIV Infections

NCT ID: NCT00002401

Safety and Effectiveness of an Anti-HIV Drug Combination in HIV-Positive Patients Who Have Failed Previous Treatment With Protease Inhibitors

Condition: HIV Infections

NCT ID: NCT00002361

Addition of Efavirenz or Nelfinavir to a Lamivudine/Zidovudine/Indinavir HIV Treatment Regimen

Condition: HIV Infections

NCT ID: NCT00000903

Effectiveness of Anti-HIV Drugs in Patients Who Have Not Received Previous Anti-HIV Drugs During Different Stages of HIV Infection

Condition: HIV Infections

NCT ID: NCT00006443

A Comparison of 141W94 and Indinavir in HIV-Infected Patients

Condition: HIV Infections

NCT ID: NCT00002202

Safety and Effectiveness of Giving Indinavir and Nelfinavir to HIV-Infected Patients

Condition: HIV Infections

NCT ID: NCT00002375

A Study of Abacavir Plus Indinavir Sulfate Plus Efavirenz in HIV-Infected Patients

Condition: HIV Infections

NCT ID: NCT00001086

A Study on the Safety and Effectiveness of L-756423 Plus Indinavir in HIV-Positive Patients Who Have Previously Taken Indinavir

Condition: HIV Infections

NCT ID: NCT00002452

The Safety and Effectiveness of Indinavir Plus Ritonavir Plus Two NRTIs in HIV-Infected Patients Who Need Early Intervention Treatment

Condition: HIV Infections

NCT ID: NCT00005118

Treatment Success and Failure in HIV-Infected Subjects Receiving Indinavir in Combination With Nucleoside Analogs: A Rollover Study for ACTG 320

Condition: HIV Infections

NCT ID: NCT00000885

A Study to Find the Best Dosing Schedule for Delavirdine, Zidovudine, and Indinavir in HIV-Positive Patients

Condition: HIV Infections

NCT ID: NCT00002236

A Study of Indinavir Sulfate Given Together With Stavudine to HIV-Positive Patients

Condition: HIV Infections

NCT ID: NCT00002354

Safety and Tolerance of Indinavir Plus Ritonavir in HIV-Positive Patients Failing Therapy With Amprenavir, Nelfinavir, or Saquinavir

Condition: HIV Infections

NCT ID: NCT00001133

A Study to Compare the Effectiveness of Two Anti-HIV Drug Combinations

Condition: HIV Infections

NCT ID: NCT00002430

A Study of Three Treatment Combinations Using Zidovudine Plus Lamivudine Plus Indinavir in HIV-Infected Patients

Condition: HIV Infections

NCT ID: NCT00001084

A Study of Indinavir Sulfate Plus Zidovudine (AZT) Plus Lamivudine in HIV-Infected Patients Who Have Taken AZT for Six or More Months

Condition: HIV Infections

NCT ID: NCT00000841

A Study on the Safety and Effectiveness of Twice-Daily Nelfinavir Plus Twice-Daily Indinavir Plus Efavirenz in HIV-Positive Patients Who Have Never Taken Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) or Protease Inhibitors

Condition: HIV Infections

NCT ID: NCT00002235

A Comparison of Two Dose Levels of Indinavir Combined With Two Nucleoside Analogue Reverse Transcriptase Inhibitors (NRTIs) in HIV-Infected Patients

Condition: HIV Infections

NCT ID: NCT00002406

A Study of Ritonavir/Indinavir Combination in HIV-Infected Patients

Condition: HIV Infections

NCT ID: NCT00002223

A Six-Month Safety and Antiviral Study in HIV-1 Seropositive, AZT-Experienced Patients With CD4 Counts Less Than or Equal to 50 Cells/mm3 to Evaluate MK-639 Alone Versus Zidovudine (AZT) and 3TC Versus the Combination of MK-639 With AZT/3TC

Condition: HIV Infections

NCT ID: NCT00002155

Safety and Effectiveness of Giving Indinavir Plus Stavudine Plus Lamivudine to HIV-Infected Children

Condition: HIV Infections

NCT ID: NCT00000901

The Pharmacokinetics and Safety of IDV/r With NRTIs in HIV/TB Co-infected Patients Receiving Rifampicin

Condition: HIV Infections; Tuberculosis

NCT ID: NCT00411996

Safety and Effectiveness of an Anti-HIV Drug Combination Taken Twice Daily

Condition: HIV Infections

NCT ID: NCT00002241

A Study to Compare the Safety and Effectiveness of Two Dosing Schedules of Lamivudine in Combination With Two Other Anti-HIV Drugs

Condition: HIV Infections

NCT ID: NCT00002442

The Safety and Effectiveness of MK-639 and Zidovudine, Used Alone and Together, in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs

Condition: HIV Infections

NCT ID: NCT00002443

A Study of Indinavir Plus Ritonavir Plus Two NRTIs vs. Nelfinavir Plus Two NRTIs in HIV Positive Patients

Condition: HIV Infections

NCT ID: NCT00541463

Study of How Indinavir (an Anti-HIV Drug) and Rifabutin (a Drug Used to Treat MAC, an HIV-Associated Disease) Interact in HIV-Positive and HIV-Negative Adults

Condition: HIV Infections

NCT ID: NCT00000877

A Study of L-735,524 in HIV-Positive Children and Adolescents

Condition: HIV Infections

NCT ID: NCT00002351

A Study to Compare the Effectiveness of a Four Drug Anti-HIV Regimen Given Alone or in Combination With GM-CSF or IL-12 to HIV-Positive Patients

Condition: HIV Infections

NCT ID: NCT00000896

Depo-Medroxyprogesterone Acetate (DMPA, Depo-Provera) Use With Certain Anti-HIV Drugs in HIV-Infected Women

Condition: HIV Infections

NCT ID: NCT00016601

Study to Determine the Pharmacokinetic Behavior of Antiretroviral Drugs in Patients Infected by HIV

Condition: HIV Infections

NCT ID: NCT00307502

Optimizing Antiretroviral Therapy in HIV-Infected Children and Adolescents

Condition: HIV Infections

NCT ID: NCT00207948

Interactions Between HIV Protease Inhibitors and Calcium Channel Blockers

Condition: HIV Infections; Cardiovascular Diseases; Hypertension

NCT ID: NCT00039975

A Study of a Combination of Four Drugs in Patients With Recent HIV Infection

Condition: HIV Infections

NCT ID: NCT00002233

A Phase III Randomized Double-Blind, Multicenter Study to Evaluate the Safety and Efficacy of 3TC/ZDV/1592U89 and 3TC/ZDV/IDV in HIV-1 Infected Antiretroviral Therapy-Naive Subjects.

Condition: HIV Infections

NCT ID: NCT00002199

A Randomized Trial of the Efficacy and Safety of a Strategy of Starting With Nelfinavir Versus Ritonavir Added to Background Antiretroviral (AR) Nucleoside Therapy in HIV-Infected Individuals With CD4+ Cell Counts Less Than or Equal to 200/mm3

Condition: HIV Infections

NCT ID: NCT00000859

Safety and Effectiveness of an Anti-HIV Drug Combination With and Without Hydroxyurea in Patients With Early HIV Infection

Condition: HIV Infections

NCT ID: NCT00006339

Withdrawn(En español)

A Study of the Effectiveness of Different Anti-HIV Treatments in HIV-Positive Individuals Who Have Been on a Protease Inhibitor-Containing Drug Regimen for at Least 16 Weeks

Condition: HIV Infections

NCT ID: NCT00000914

Ritonavir and Indinavir in Children Failing Other Anti-HIV Treatment

Condition: HIV Infections

NCT ID: NCT00012519

Differences Between Women and Men Taking a Combination of Indinavir, Ritonavir, Enteric-Coated Didanosine, and Stavudine Who Previously Took Anti-HIV Drugs

Condition: HIV Infections

NCT ID: NCT00006397

The Anti-HIV Effects of Saquinavir Soft Gelatin Capsules Versus Indinavir in Patients Who Have Used Saquinavir Hard Gelatin Capsules for One Year

Condition: HIV Infections

NCT ID: NCT00000848

Not yet recruiting(En español)

A Study to Evaluate the Use of a Protease Inhibitor and of Interleukin-2 (IL-2) in the Treatment of Early HIV Infection

Condition: HIV Infections

NCT ID: NCT00006154

Indinavir Plus Efavirenz Plus Adefovir Dipivoxil in HIV-Infected Patients Who Have Not Had Success With Nelfinavir

Condition: HIV Infections

NCT ID: NCT00002220

A Study of Indinavir Taken With or Without DMP 266

Condition: HIV Infections

NCT ID: NCT00002393

Safety and Effectiveness of 3 Anti-HIV Treatments in Patients Who Have Failed Previous Treatments Containing Nelfinavir

Condition: HIV Infections

NCT ID: NCT00006326

A Study of 141W94 in Combination With Other Anti-HIV Drugs

Condition: HIV Infections

NCT ID: NCT00002372

Drug Interactions of Amprenavir and Efavirenz, in Combination With a Second Protease Inhibitor, in HIV-Negative Volunteers

Condition: HIV Infections

NCT ID: NCT00005762

A Study of the Safety and Effectiveness of Hydroxyurea in Patients on Potent Antiretroviral Therapy and Who Have Less Than 200 Copies/ml of HIV RNA in Their Blood

Condition: HIV Infections

NCT ID: NCT00000916

Controlled Clinical Trial of Antiviral Cytotoxic T Lymphocyte (CTL) Infusion Following Combination Antiretroviral Drug Therapy for Asymptomatic HIV-1 Infection

Condition: HIV Infections

NCT ID: NCT00000875

A Study of Three Anti-HIV Drug Combinations in Patients Who Have Taken Amprenavir

Condition: HIV Infections

NCT ID: NCT00001095

A Pharmacokinetic (PK) Study of a Combination of Indinavir, Ritonavir, and Amprenavir

Condition: HIV Infections

NCT ID: NCT00148785

Use of Combined Antiretroviral Therapy to Determine Sites of Persistent HIV Infection

Condition: HIV Infection

NCT ID: NCT00001644

The Safety and Effectiveness of Indinavir Sulfate Plus Efavirenz

Condition: HIV Infections

NCT ID: NCT00002387

Virologic and Immunologic Activity of Continued Lamivudine (3TC) vs Delavirdine (DLV) in Combination With Indinavir (IDV) and Zidovudine (ZDV) or Stavudine (d4T) in 3TC-Experienced Subjects

Condition: HIV Infections

NCT ID: NCT00000882

A Multicenter, Open-Label, Randomized, 24-Week Study to Compare the Safety and Activity of Indinavir Sulfate, 800 Mg q 8 h Versus 1,200 Mg q 12 h in Combination With Zidovudine and 3TC

Condition: HIV Infections

NCT ID: NCT00002208

A Study to Compare the Safety and Effectiveness of Indinavir Combined With Stavudine and Lamivudine

Condition: HIV Infections

NCT ID: NCT00002424

Suspended

Pharmacokinetic Study of Indinavir Drug Levels When Boosted With Ritonavir in Thailand

Condition: HIV Infection

NCT ID: NCT00197639

HIV Infection And Metabolic Abnormalities Protocol 1 (HAMA001)

Condition: HIV-Associated Lipodystrophy Syndrome; Cardiovascular Disease

NCT ID: NCT00192660

Efficacy and Tolerability of an Antiretroviral Bi-Therapy in HIV Infected Patients With Multidrug Resistance

Condition: HIV Infections

NCT ID: NCT00120783

A Study of 1592U89 in Combination With Protease Inhibitors in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs

Condition: HIV Infections

NCT ID: NCT00002440

The Effectiveness of HIV RNA Viral Load Testing in Determining Treatment Type in HIV-Infected Patients

Condition: HIV Infections

NCT ID: NCT00002376

The Effectiveness of GM-CSF in HIV-Positive Patients Who Are Also Receiving Anti-HIV Therapy

Condition: HIV Infections

NCT ID: NCT00000850

A Study to Compare The Ability of Different Anti-HIV Drugs to Decrease Viral Load After Nelfinavir (an Anti-HIV Drug)Treatment Failure

Condition: HIV Infections

NCT ID: NCT00000918

A Study on Amprenavir in Combination With Other Anti-HIV Drugs in HIV-Positive Patients

Condition: HIV Infections

NCT ID: NCT00000912

Effects on the Immune System of Anti-HIV Drugs in Patients Recently Infected With HIV

Condition: HIV Infections

NCT ID: NCT00001119

A Study to Evaluate Various Combinations of Anti-HIV Medications to Treat Early HIV Infection

Condition: HIV Infections

NCT ID: NCT00000919

A Study to Evaluate the Long-Term Effectiveness of Three Anti-HIV Drug Regimens in HIV Infected Patients Who Have Never Been Exposed to Highly Active Antiretroviral Therapy (HAART)

Condition: HIV Infections

NCT ID: NCT00000922

A Randomized Trial of L-735,524, An Inhibitor of the HIV Protease Enzyme, and Interleukin-2 in Persons Infected With HIV (NOTE: Only For Patients Who Previously Completed NIAID 93 CC-113)

Condition: HIV Infections

NCT ID: NCT00000804

The Safety and Effectiveness of Lamivudine Plus Stavudine or Zidovudine in HIV-Infected Patients Who Have Taken Zidovudine

Condition: HIV Infections

NCT ID: NCT00002371

A Phase II Study of Intermittent Recombinant Human Interleukin-2 (rhIL-2) by Intravenous or Subcutaneous Administration in Subjects With HIV Infection on Highly Active Antiretroviral Therapy (HAART) Compared to HAART Alone

Condition: HIV Infections

NCT ID: NCT00000870

Safety and Effectiveness of CPI-1189 in HIV-Infected Males on Combination Anti-HIV Drug Therapy

Condition: AIDS Dementia Complex; HIV Infections

NCT ID: NCT00002209

A Study of Three Drug Combination Therapies in HIV-Infected Patients Who Have Never Been Treated With Anti-HIV Drugs

Condition: HIV Infections

NCT ID: NCT00002407

Influence of the MDR1 Genotype on Blood Levels of Indinavir and Saquinavir in Healthy Volunteers

Condition: Healthy; HIV Infections

NCT ID: NCT00050180

Randomised Trial of Structured Treatment Interruption of HAART in HIV-Infected Adults in Abidjan (ANRS 1269 TRIVACAN)

Condition: HIV Infections

NCT ID: NCT00158405

The Effect of Milk Thistle on the Pharmacokinetics of Indinavir

Condition: HIV Infection; Healthy

NCT ID: NCT00011635

Evaluation of Therapeutic Drug Monitoring of Protease Inhibitors on Virologic Success and Tolerance of Highly Active Antiretroviral Therapy (HAART)

Condition: HIV Infections

NCT ID: NCT00122590

Using Drug Levels and Drug Resistance Testing to Select Effective Anti-HIV Drug Combinations in Patients With Drug-resistant HIV

Condition: HIV Infections

NCT ID: NCT00027339

A Prospective Cohort of Children With HIV Infection

Condition: HIV Infections

NCT ID: NCT00476606

Recruiting

A Pilot Study of the Short-Term Effects of Antiretroviral Management Based on Plasma Genotypic Antiretroviral Resistance Testing (GART) Compared With Antiretroviral Management Without Plasma GART

Condition: HIV Infections

NCT ID: NCT00000874

Treatment With Interleukin-2 (IL-2) Plus Combination Anti-HIV-Drug Therapy (HAART) for Patients Formerly in ACTG 328

Condition: HIV Infections

NCT ID: NCT00000923

A Comparison of Three Drug Combinations Containing Clarithromycin in the Treatment of Mycobacterium Avium Complex (MAC) Disease in Patients With AIDS

Condition: Mycobacterium Avium-intracellulare Infection; HIV Infections

NCT ID: NCT00001058

Safety and Survival of Genetically Modified White Blood Cells in HIV-Infected Persons - A Study in Identical Twin Pairs

Condition: Acquired Immunodeficiency Syndrome; HIV Infection

NCT ID: NCT00001353

The Study of HIV Protease Inhibitors and Their Effects on Glucose Metabolism

Condition: Diabetes; HIV Infections; Insulin Resistance

NCT ID: NCT00259727

The Safety and Effectiveness of 1592U89 Plus 141W94 Plus DMP 266 in Patients With HIV Who Developed a Resistance to Protease Inhibitors

Condition: HIV Infections

NCT ID: NCT00002213

Pharmacokinetic Study of 2 Doses of ATV/r OD + 2 NRTIs in Thai HIV-1 Infected Patients

Condition: HIV Infections

NCT ID: NCT00411957

A Study of 141W94 Used Alone or in Combination With Zidovudine Plus 3TC in HIV-Infected Patients

Condition: HIV Infections

NCT ID: NCT00001085

Psychiatric and Antiretroviral Medication Concentrations in HIV-infected and Uninfected Children and Adolescents

Condition: ADHD; HIV

NCT ID: NCT01232361

Recruiting

Capravirine to Treat Children With HIV Infection

Condition: HIV Infection

NCT ID: NCT00006519

Viracept Expanded Access Program

Condition: HIV Infections

NCT ID: NCT00002165

Treatment of Classical Non-HIV-Related Kaposi's Sarcoma With the Antiviral Drug Indinavir

Condition: Classical Kaposi's Sarcoma

NCT ID: NCT00362310

Treatment With Indinavir and Chemotherapy for Advanced Classical Kaposi's Sarcoma

Condition: Kaposi's Sarcoma

NCT ID: NCT01067690

Recruiting

Anti-HIV Drug Regimens and Treatment-Switching Guidelines in HIV Infected Children

Condition: HIV Infections

NCT ID: NCT00039741

Lopinavir/Ritonavir Monotherapy in Children

Condition: HIV Infections

NCT ID: NCT00626301

Efficacy and Safety of SQV in Patients Who Have Chronic IDV Nephrotoxicity

Condition: IDV Associated Nephrotoxicity

NCT ID: NCT00477048

Paclitaxel in Treating Patients With AIDS-Related Kaposi's Sarcoma

Condition: Sarcoma

NCT ID: NCT00003008